Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens

Daniel Podzamczer, Antonio Rivero, A. López-Lirola et al.|Journal of Antimicrobial Chemotherapy|2023

Cited by 10